Management of dysphagia in the patient with head and neck cancer during COVID-19 pandemic : Practical strategy
© 2020 Wiley Periodicals, Inc..
The global pandemic of 2019 novel coronavirus disease (COVID-19) has tremendously altered routine medical service provision and imposed unprecedented challenges to the health care system. This impacts patients with dysphagia complications caused by head and neck cancers. As this pandemic of COVID-19 may last longer than severe acute respiratory syndrome (SARS) in 2003, a practical workflow for managing dysphagia is crucial to ensure a safe and efficient practice to patients and health care personnel. This document provides clinical practice guidelines based on available evidence to date to balance the risks of SARS-CoV-2 exposure with the risks associated with dysphagia. Critical considerations include reserving instrumental assessments for urgent cases only, optimizing the noninstrumental swallowing evaluation, appropriate use of personal protective equipment (PPE), and use of telehealth when appropriate. Despite significant limitations in clinical service provision during the pandemic of COVID-19, a safe and reasonable dysphagia care pathway can still be implemented with modifications of setup and application of newer technologies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
---|---|
Enthalten in: |
Head & neck - 42(2020), 7 vom: 15. Juli, Seite 1491-1496 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ku, Peter K M [VerfasserIn] |
---|
Links: |
---|
Themen: |
25BB7EKE2E |
---|
Anmerkungen: |
Date Completed 20.07.2020 Date Revised 18.12.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/hed.26224 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309324289 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309324289 | ||
003 | DE-627 | ||
005 | 20231225133649.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/hed.26224 |2 doi | |
028 | 5 | 2 | |a pubmed24n1031.xml |
035 | |a (DE-627)NLM309324289 | ||
035 | |a (NLM)32348591 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ku, Peter K M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Management of dysphagia in the patient with head and neck cancer during COVID-19 pandemic |b Practical strategy |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.07.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 Wiley Periodicals, Inc. | ||
520 | |a The global pandemic of 2019 novel coronavirus disease (COVID-19) has tremendously altered routine medical service provision and imposed unprecedented challenges to the health care system. This impacts patients with dysphagia complications caused by head and neck cancers. As this pandemic of COVID-19 may last longer than severe acute respiratory syndrome (SARS) in 2003, a practical workflow for managing dysphagia is crucial to ensure a safe and efficient practice to patients and health care personnel. This document provides clinical practice guidelines based on available evidence to date to balance the risks of SARS-CoV-2 exposure with the risks associated with dysphagia. Critical considerations include reserving instrumental assessments for urgent cases only, optimizing the noninstrumental swallowing evaluation, appropriate use of personal protective equipment (PPE), and use of telehealth when appropriate. Despite significant limitations in clinical service provision during the pandemic of COVID-19, a safe and reasonable dysphagia care pathway can still be implemented with modifications of setup and application of newer technologies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a coronavirus | |
650 | 4 | |a dysphagia | |
650 | 4 | |a head and neck | |
650 | 4 | |a management | |
650 | 7 | |a Contrast Media |2 NLM | |
650 | 7 | |a Barium Sulfate |2 NLM | |
650 | 7 | |a 25BB7EKE2E |2 NLM | |
700 | 1 | |a Holsinger, Floyd Christopher |e verfasserin |4 aut | |
700 | 1 | |a Chan, Jason Y K |e verfasserin |4 aut | |
700 | 1 | |a Yeung, Zenon W C |e verfasserin |4 aut | |
700 | 1 | |a Chan, Becky Y T |e verfasserin |4 aut | |
700 | 1 | |a Tong, Michael C F |e verfasserin |4 aut | |
700 | 1 | |a Starmer, Heather M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Head & neck |d 1996 |g 42(2020), 7 vom: 15. Juli, Seite 1491-1496 |w (DE-627)NLM012791806 |x 1097-0347 |7 nnns |
773 | 1 | 8 | |g volume:42 |g year:2020 |g number:7 |g day:15 |g month:07 |g pages:1491-1496 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/hed.26224 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 42 |j 2020 |e 7 |b 15 |c 07 |h 1491-1496 |